Taysha Gene Therapies, Inc. TSHA 深 沪
等待开盘 06-25 09:30:00 美东时间
6.94
+0.080
+1.17%
华盛通- 最 高7.06
- 今 开6.86
- 成交量 206.32万股
- 最 低 6.83
- 昨 收 6.86
- 总市值 199.43万
- 52周最高 7.30
- 市盈率 静 --
- 换手率 0.72%
- 52周最低 2.33
- 委 比 -0.48%
- 总股本 0.00亿
- 历史最高 33.35
- 量 比 0.67
- 振 幅 3.35%
- 历史最低 0.50
- 每 手 1
- 风险率 1.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多9 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers American Shared Hospital (AMEX:AMS) stock rose 14.2% to $1.61 during Wednesday's after-market session. The market value of their outstanding shares is at $9.7 million. Greenland Mines (NASDAQ:GRML) stock moved upwards by 7.18% to $0.24. The company's market cap stands at $34.7 million. Lunai...
今天 05:05
Taysha Gene Therapies Commences $200M Common Stock Offering
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that it has commenced an underwritten pu...
今天 04:03
美股大行评级 | 美银上调美光科技目标价从950美元升至1500美元，上调迈威尔科技目标价从240美元升至365美元
今日重点评级关注：摩根士丹利：维持杜邦"标配"评级，目标价从52美元升至156美元；蒙特利尔银行：维持Taysha Gene Therapies"跑赢大市"评级，目标价从10美元升至14美元
06-24 14:08
Taysha Completes REVEAL Dosing, Advances Rett Gene Therapy
Taysha Gene Therapies ( ($TSHA) ) has provided an announcement. On June 22, 202...
06-22 20:30
Sophia Genetics, Ormat Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining over 100 points on Wednesday. Shares of Sophia Genetics SA (NASDAQ:SOPH) fell sharply in pre-market trading. Sophia Genetics priced its underwritten public offering of 10.526 million ordinary shares at $4.75 each, ra...
06-17 20:03
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Taysha Gene Therapies授予四位新员工总计714,700股RSU和468,600股股票期权，归属期为四年。RSU和期权均根据2023年激励计划授予，期权行使价为每股5.97美元，有效期10年。公司专注于开发中枢神经系统单基因疾病的AAV基因疗法。
06-05 12:01
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Taysha Gene Therapies Q1 EPS $(0.12) Misses $(0.10) Estimate
Taysha Gene Therapies (NASDAQ:TSHA) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) by 20 percent. This is a 50 percent decrease over losses of $(0.08) per share from
05-06 20:06
Taysha Gene Therapies To Reveal New Preclinical Data Supporting Construct Design Of TSHA-102 For Rett Syndrome At The ASGCT 2026 Annual Meeting
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the
04-28 05:30
